Video

Northwell Health Cancer Institute: Patients and Physicians Working Together, Moving Forward

The Pancreatic Cancer Center team of the Northwell Health Cancer Institute has developed a collaborative care model to treat this rapid-moving form of cancer. This edition of Health Story features an informal conversation with Dr. Matthew Weiss, deputy physician-in-chief and director of surgical oncology of the Northwell Health Cancer Institute and nationally-renowned hepatopancreatobiliary surgeon.

The Pancreatic Cancer Center team of the Northwell Health Cancer Institute has developed a collaborative care model to treat this rapid-moving form of cancer. This edition of Health Story features an informal conversation with Dr. Matthew Weiss, deputy physician-in-chief and director of surgical oncology of the Northwell Health Cancer Institute and nationally-renowned hepatopancreatobiliary surgeon. Dr. Weiss describes the goals and practices of the Pancreatic Cancer Center and the Institute, and explains how its multi-disciplinary approach to targeting cancers supports and benefits physician-patient relationships, and encourages participation in research toward more successful outcomes.

Related Videos
Gregory J. Riely, MD, PhD, and Benjamin Besse, MD, on progression patterns and subsequent therapies after lorlatinib in ALK-positive NSCLC.
Gregory J. Riely, MD, PhD, and Benjamin Besse, MD, discuss preclinical CNS data for the ROS1 inhibitor zidesamtinib.
Gregory J. Riely, MD, PhD, and Benjamin Besse, MD, discuss data for zidesamtinib in ROS1-positive non–small cell lung cancer.
Mohammed Najeeb Al Hallak, MD, MS, and Sakti Chakrabarti, MD, discuss ongoing research in gastrointestinal cancers.
Mohammed Najeeb Al Hallak, MD, MS, and Sakti Chakrabarti, MD, discuss research building upon approved combinations in unresectable hepatocellular carcinoma.
Mohammed Najeeb Al Hallak, MD, MS, and Sakti Chakrabarti, MD, on trastuzumab deruxtecan–based regimens in advanced HER2-positive GI cancers.
Mohammed Najeeb Al Hallak, MD, MS, and Sakti Chakrabarti, MD, on final overall survival data from the KEYNOTE-811 trial.
Mohammed Najeeb Al Hallak, MD, MS, and Sakti Chakrabarti, MD, on data for neoadjuvant nivolumab plus ipilimumab in dMMR colon cancer.
Yair Lotan, MD, UT Southwestern Medical Center
Alan Tan, MD, Vanderbilt-Ingram Cancer Center